Clorox Valuation

Is CXX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CXX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CXX (€157.4) is trading below our estimate of fair value (€273.56)

Significantly Below Fair Value: CXX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CXX?

Key metric: As CXX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CXX. This is calculated by dividing CXX's market cap by their current earnings.
What is CXX's PE Ratio?
PE Ratio57x
EarningsUS$357.00m
Market CapUS$20.35b

Price to Earnings Ratio vs Peers

How does CXX's PE Ratio compare to its peers?

The above table shows the PE ratio for CXX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average30.4x
HEN3 Henkel KGaA
19.8x6.5%€32.7b
BEI Beiersdorf
37.3x12.8%€27.5b
ESSITY B Essity
17.3x8.8%SEK 204.4b
CHD Church & Dwight
47.3x18.2%US$26.0b
CXX Clorox
57x20.1%€20.4b

Price-To-Earnings vs Peers: CXX is expensive based on its Price-To-Earnings Ratio (57x) compared to the peer average (30.4x).


Price to Earnings Ratio vs Industry

How does CXX's PE Ratio compare vs other companies in the Global Household Products Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CXX 57.0xIndustry Avg. 17.1xNo. of Companies17PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CXX is expensive based on its Price-To-Earnings Ratio (57x) compared to the Global Household Products industry average (17.1x).


Price to Earnings Ratio vs Fair Ratio

What is CXX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CXX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio57x
Fair PE Ratio31x

Price-To-Earnings vs Fair Ratio: CXX is expensive based on its Price-To-Earnings Ratio (57x) compared to the estimated Fair Price-To-Earnings Ratio (31x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CXX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€157.40
€156.65
-0.5%
8.5%€180.08€132.44n/a19
Dec ’25€158.20
€154.68
-2.2%
8.2%€178.13€131.70n/a19
Nov ’25€145.20
€149.55
+3.0%
8.2%€173.49€128.27n/a19
Oct ’25€146.60
€139.26
-5.0%
9.2%€168.94€117.44n/a21
Sep ’25€142.00
€132.99
-6.3%
7.5%€152.95€115.16n/a21
Aug ’25€122.80
€134.68
+9.7%
8.7%€157.54€113.06n/a20
Jul ’25€127.40
€138.86
+9.0%
7.1%€158.34€121.08n/a19
Jun ’25€119.00
€139.74
+17.4%
6.8%€156.52€121.53n/a19
May ’25€138.80
€142.61
+2.7%
6.9%€158.07€123.46n/a19
Apr ’25€140.60
€144.15
+2.5%
5.8%€157.03€129.32n/a19
Mar ’25€141.80
€144.15
+1.7%
5.8%€156.88€129.19n/a19
Feb ’25€134.40
€129.45
-3.7%
10.6%€153.10€107.91n/a18
Jan ’25€128.00
€127.85
-0.1%
10.8%€152.06€105.34n/a20
Dec ’24€131.40
€125.40
-4.6%
11.1%€151.29€105.44€158.2020
Nov ’24€109.20
€130.45
+19.5%
13.5%€161.46€111.42€145.2018
Oct ’24€121.60
€145.62
+19.7%
9.4%€175.05€120.17€146.6019
Sep ’24€144.20
€145.37
+0.8%
9.5%€169.79€116.56€142.0018
Aug ’24€137.40
€139.12
+1.3%
10.5%€166.22€105.12€122.8018
Jul ’24€145.40
€143.08
-1.6%
9.9%€170.22€114.09€127.4018
Jun ’24€147.80
€145.32
-1.7%
9.9%€172.16€114.77€119.0019
May ’24€150.60
€131.56
-12.6%
11.5%€150.53€103.09€138.8019
Apr ’24€141.40
€131.66
-6.9%
11.4%€153.91€100.74€140.6020
Mar ’24€146.40
€132.22
-9.7%
11.5%€154.29€100.99€141.8020
Feb ’24€132.66
€125.62
-5.3%
11.3%€149.29€100.13€134.4019
Jan ’24€133.30
€130.23
-2.3%
12.2%€156.62€97.41€128.0019
Dec ’23€141.86
€130.78
-7.8%
11.9%€155.78€98.08€131.4019

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 12:52
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The Clorox Company is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John StaszakArgus Research Company
Edward LewisAtlantic Equities LLP
Ishan MajumdarBaptista Research